KA Imaging, a 2016 CAAP Company, is one of the first three companies to receive funding via FACIT's new Prospects Oncology Fund.
The non-dilutive funding provided by FACIT - Fight Against Cancer Innovation Trust - will help KA Imaging to develop their nascent technology in Ontario. This support also aligns with FACIT's Prospects Fund as a key gateway to oncology innovation opportunities in the province. The Fund plays a critical role in helping to de-risk early stage innovations and increase favourable exposure to FACIT's larger network of commercial partners and investors.
Read the press release here.